These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1673593)

  • 1. Effects of a histamine type-2 receptor antagonist (BMY-25368) on gastric secretion in horses.
    Orsini JA; Dreyfuss DJ; Vecchione J; Spencer PA; Uhlman R
    Am J Vet Res; 1991 Jan; 52(1):108-10. PubMed ID: 1673593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a histamine type 2 receptor antagonist, BMY-26539-01, on equine gastric acid secretion.
    Orsini JA; Spencer PA
    Can J Vet Res; 2001 Jan; 65(1):55-9. PubMed ID: 11227196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histamine-induced gastric acid secretion in horses.
    Kitchen DL; Merritt AM; Burrow JA
    Am J Vet Res; 1998 Oct; 59(10):1303-6. PubMed ID: 9781466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the novel histamine H2-antagonist 5,6-dimethyl-2-[4-[3-(1- piperidinomethyl)phenoxy]-(z)-2-butenylamino]-4(1H)-pyrimidine dihydrochloride on histamine-induced gastric acid secretion in Heidenhain pouch dogs.
    Uchida M; Ohba S; Ikarashi Y; Misaki N; Kawano O
    Arzneimittelforschung; 1993 Aug; 43(8):873-6. PubMed ID: 8105784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
    Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
    Muramatsu M; Isobe Y; Arai I; Hirose-Kijima H; Usuki-Ito C; Nagai H; Aihara H; Otomo S
    Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic administration of H2-antagonists does not alter gastric secretory responses to histamine, or the antisecretory activity of sufotidine.
    Stables R; Humphray JM; Reeves JJ
    Aliment Pharmacol Ther; 1990; 4 Suppl 1():7-13. PubMed ID: 1983348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of BMY-25368, a potent and long-acting histamine H2-receptor antagonist, on gastric secretion and aspirin-induced gastric lesions in the dog.
    Cavanagh RL; Buyniski JP
    Aliment Pharmacol Ther; 1989 Jun; 3(3):299-313. PubMed ID: 2577694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs.
    Lin TM; Evans DC; Warrick MW; Pioch RP
    J Pharmacol Exp Ther; 1986 Nov; 239(2):406-10. PubMed ID: 2877081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of aspirin-induced gastric mucosal injury by histamine H2 receptor antagonists: a crossover endoscopic and intragastric pH study in the dog.
    Cavanagh RL; Buyniski JP; Schwartz SE
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1179-84. PubMed ID: 2891837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response curve analysis of gastric secretory responses in the dog and man to impromidine: a new histamine-H2-receptor agonist.
    McIsaac RL; Johnston BJ; Flannery MC
    J Pharmacol Exp Ther; 1983 Apr; 225(1):186-90. PubMed ID: 6131998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the H2-antagonist niperotidine on intragastric acidity in healthy subjects undergoing 24-hour pH-monitoring.
    Palasciano G; Maggi V; Portincasa P
    Ital J Gastroenterol; 1990 Oct; 22(5):291-4. PubMed ID: 1983712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisecretory effects of two new histamine H2-receptor antagonists.
    Bickel M; Herling AW; Rising TJ; Wirth K
    Arzneimittelforschung; 1986 Sep; 36(9):1358-63. PubMed ID: 2878669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisecretory and antilesional effect of a new histamine H2-receptor antagonist, IT-066, in rats.
    Isobe Y; Nagai H; Muramatsu M; Aihara H; Otomo S
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1078-82. PubMed ID: 1979811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new histamine H2-receptor antagonist ranitidine. Duration of action.
    Dammann HG; Simon B
    Scand J Gastroenterol Suppl; 1981 Jun; 69():39-43. PubMed ID: 6119781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nocturnal acid suppression with a new H2 receptor antagonist--nizatidine.
    Dammann HG; Gottlieb WR; Walter TA; Dreyer M; Müller P; Simon B; Keohane P
    Hepatogastroenterology; 1986 Oct; 33(5):217-20. PubMed ID: 2879782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gastric acid secretion and histamine H2 receptor antagonists].
    Gespach C; Emami S; Di Gioia Y; Chastre E
    Gastroenterol Clin Biol; 1990; 14(12):982-94. PubMed ID: 1981198
    [No Abstract]   [Full Text] [Related]  

  • 19. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.
    Brittain RT; Daly MJ
    Scand J Gastroenterol Suppl; 1981 Jun; 69():1-9. PubMed ID: 6119770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
    Cavanagh RL; Usakewicz JJ; Buyniski JP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.